| Company/Division name | Padagis LLC |
| Parent company | Altaris Capital Partners |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2025 |
| Year reshoring implemented or to be implemented: | 2026 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 36 |
| City reshored to: | Minneapolis |
| State(s) reshored to: | MN |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | generic pharmaceuticals, naloxone nasal spray |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Higher productivity, Proximity to customers/market |
